FactのEV/EBIT
FactのEV/EBITは何ですか。
Fact, Inc.のEV/EBITはN/Aです。
EV/EBITの定義は何ですか。
Enterprise value to earnings before interest and taxes (EV/EBIT) is a financial ratio used to measure if a stock is priced appropriately to similar stocks and the market. It is similar to the P/E ratio.
ttm (trailing twelve months)
The EV/EBIT ratio addresses some of the shortcomings of the P/E ratio. Instead of taking market capitalization, the ratio uses enterprise value, as it takes into account the true value of the company. Enterprise value includes both equity and debt. It is calculated as:
Enterprise value = market cap + total debt – cash and cash equivalents
The EV/EBIT ratio is useful in comparing peers within the wider market. A high EV/EBIT ratio indicates that a company’s stock is overvalued. On the opposite, a low EV/EBIT ratio indicates that a company’s stock is undervalued. The lower the ratio, the more financially stable a company should be. However, investors and analyst should use other ratios and information to get a full picture of a company’s financial state and actual value.
OTCのセクタIndustrialsにおけるEV/EBITの企業と比べるFact
Factは何をしますか。
Fact, Inc. engages in the art verification and authentication, sports memorabilia, and fine art businesses. It is developing a front-end user interface, as well as modifying existing ballistics firmware for a comprehensive verification, tracking, and reporting system using white light interferometry to take a non-destructive 3D digital fingerprint of the art using approximately 100,000 unique images. The company was formerly known as Tiburon International Trading Corp. and changed its name to Fact, Inc. in November 2020. FACT, Inc. is headquartered in Toronto, Canada. As of October 5, 2020, Fact, Inc. operates as a subsidiary of Kryptos Art Technologies, Inc.
Factと類似のev/ebit
- Frequency ExchangeのEV/EBITはN/Aです。
- TorstarのEV/EBITはN/Aです。
- Miragen Therapeutics IncのEV/EBITはN/Aです。
- MitescoのEV/EBITはN/Aです。
- Monumental Minerals CorpのEV/EBITはN/Aです。
- C4 TherapeuticsのEV/EBITはN/Aです。
- FactのEV/EBITはN/Aです。
- BioCardiaのEV/EBITはN/Aです。
- Comprehensive Healthcare SystemsのEV/EBITはN/Aです。
- ProgenityのEV/EBITはN/Aです。
- THC TherapeuticsのEV/EBITはN/Aです。
- RiceBran TechnologiesのEV/EBITはN/Aです。
- BioAtlaのEV/EBITはN/Aです。